Journal article icon

Journal article

The Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic attack (PERFORM) study: baseline characteristics of the population.

Abstract:

BACKGROUND: The Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic attack (PERFORM) study is an international double-blind, randomized controlled trial designed to investigate the superiority of the specific TP receptor antagonist terutroban (30 mg/day) over aspirin (100 mg/day), in reducing cerebrovascular and cardiovascular events in patients with a recent history of ischemic stroke ...

Expand abstract
Publication status:
Published

Actions


Access Document


Publisher copy:
10.1159/000216835

Authors


Expand authors...
Journal:
Cerebrovascular diseases (Basel, Switzerland)
Volume:
27
Issue:
6
Pages:
608-613
Publication date:
2009-01-01
DOI:
EISSN:
1421-9786
ISSN:
1015-9770
URN:
uuid:ede96413-a22a-48b2-a3b9-e41dc8347452
Source identifiers:
119560
Local pid:
pubs:119560

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP